Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
+$784M |
| 2 |
Amgen
AMGN
|
+$695M |
| 3 |
Eli Lilly
LLY
|
+$512M |
| 4 |
Apple
AAPL
|
+$485M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$471M |
Top Sells
| 1 |
Adobe
ADBE
|
+$935M |
| 2 |
NVIDIA
NVDA
|
+$837M |
| 3 |
TJX Companies
TJX
|
+$533M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$364M |
| 5 |
Starbucks
SBUX
|
+$357M |
Sector Composition
| 1 | Technology | 35.94% |
| 2 | Healthcare | 18.89% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Crinetics Pharmaceuticals
CRNX
$3.31B
| $110M | 0.06% |
2,455,661
+477,489
| +24% | +$21.4M |
|
252
BridgeBio Pharma
BBIO
$10.4B
| $109M | 0.06% |
4,312,531
+999,825
| +30% | +$25.3M |
|
253
Shift4
FOUR
$5.99B
| $107M | 0.06% |
1,454,714
+19,824
| +1% | +$1.45M |
|
254
89bio
ETNB
$1.27B
| $106M | 0.06% |
13,276,110
+672,728
| +5% | +$5.39M |
|
255
Regeneron Pharmaceuticals
REGN
$59.2B
| $106M | 0.06% |
100,424
-3,568
| -3% | -$3.75M |
|
256
Arcellx
ACLX
$3.94B
| $105M | 0.06% |
1,902,618
+380,309
| +25% | +$21M |
|
|
ALTR
257
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $105M | 0.06% |
1,068,822
+831
| +0.1% | +$81.5K |
|
258
Legend Biotech
LEGN
$6.39B
| $104M | 0.06% |
2,359,056
+345,044
| +17% | +$15.3M |
|
259
Surgery Partners
SGRY
$2.83B
| $103M | 0.05% |
4,312,918
+1,808,670
| +72% | +$43M |
|
260
Gates Industrial
GTES
$6.58B
| $102M | 0.05% |
6,477,036
+12,286
| +0.2% | +$194K |
|
|
SUM
261
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $101M | 0.05% |
2,769,306
-73,419
| -3% | -$2.69M |
|
262
BellRing Brands
BRBR
$4.51B
| $101M | 0.05% |
1,768,608
-189,072
| -10% | -$10.8M |
|
263
Telus
TU
$25.1B
| $101M | 0.05% |
6,652,731
+2,080,699
| +46% | +$31.5M |
|
264
Maximus
MMS
$4.98B
| $99.6M | 0.05% |
1,162,439
-92,097
| -7% | -$7.89M |
|
265
Donaldson
DCI
$9.47B
| $99.4M | 0.05% |
1,388,500
-644
| -0% | -$46.1K |
|
266
UL Solutions
ULS
$12.8B
| $98.2M | 0.05% |
+2,328,210
| New | +$98.2M |
|
267
Cisco
CSCO
$264B
| $97.7M | 0.05% |
2,056,523
-66,617
| -3% | -$3.16M |
|
268
Agree Realty
ADC
$8.04B
| $96.4M | 0.05% |
1,556,436
+7,373
| +0.5% | +$457K |
|
269
Aptiv
APTV
$17.9B
| $96.2M | 0.05% |
1,366,240
-616,229
| -31% | -$43.4M |
|
270
Wynn Resorts
WYNN
$12.8B
| $95.6M | 0.05% |
1,068,586
-57,132
| -5% | -$5.11M |
|
271
HealthEquity
HQY
$8.02B
| $94.9M | 0.05% |
1,101,473
+758
| +0.1% | +$65.3K |
|
272
Advanced Drainage Systems
WMS
$11.5B
| $94.3M | 0.05% |
588,187
+14,970
| +3% | +$2.4M |
|
273
Saia
SAIA
$8.31B
| $93.6M | 0.05% |
197,301
-21,036
| -10% | -$9.98M |
|
274
Mirion Technologies
MIR
$5.21B
| $93.3M | 0.05% |
8,685,267
-717,847
| -8% | -$7.71M |
|
275
Kirby Corp
KEX
$4.98B
| $93.2M | 0.05% |
778,149
-177,438
| -19% | -$21.2M |
|